Found: 38
Select item for more details and to access through your institution.
Completing the Translation.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 183, doi. 10.1634/theoncologist.2019-0650
- By:
- Publication type:
- Article
Potential Roles for PD‐1 Inhibition and Cabozantinib in Patients with Metastatic Non‐Clear Cell Renal Cell Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 186, doi. 10.1634/theoncologist.2019-0657
- By:
- Publication type:
- Article
Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer‐Related Pain.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 189, doi. 10.1634/theoncologist.2019-0540
- By:
- Publication type:
- Article
Workup and Management of Immune‐Mediated Colitis in Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 197, doi. 10.1634/theoncologist.2018-0304
- By:
- Publication type:
- Article
A Rare EGFR–SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 203, doi. 10.1634/theoncologist.2019-0405
- By:
- Publication type:
- Article
Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 208, doi. 10.1634/theoncologist.2019-0717
- By:
- Publication type:
- Article
Premature Termination of a Randomized Controlled Trial on Image‐Guided Stereotactic Body Radiotherapy of Metastatic Spinal Cord Compression.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 210, doi. 10.1634/theoncologist.2019-0672
- By:
- Publication type:
- Article
Effects of High Anxiety Scores on Surgical and Overall Treatment Plan in Patients with Breast Cancer Treated with Neoadjuvant Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 212, doi. 10.1634/theoncologist.2019-0512
- By:
- Publication type:
- Article
From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next‐Generation Sequencing‐Based Circulating Tumor DNA Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 218, doi. 10.1634/theoncologist.2019-0239
- By:
- Publication type:
- Article
Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 229, doi. 10.1634/theoncologist.2019-0553
- By:
- Publication type:
- Article
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 235, doi. 10.1634/theoncologist.2019-0441
- By:
- Publication type:
- Article
The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 244, doi. 10.1634/theoncologist.2019-0469
- By:
- Publication type:
- Article
Nivolumab for the Treatment of Patients with Metastatic Non‐Clear Cell Renal Cell Carcinoma (nccRCC): A Single‐Institutional Experience and Literature Meta‐Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 252, doi. 10.1634/theoncologist.2019-0372
- By:
- Publication type:
- Article
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 259, doi. 10.1634/theoncologist.2019-0403
- By:
- Publication type:
- Article
An Analysis of Recent FDA Oncology Scientific Publications.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 266, doi. 10.1634/theoncologist.2019-0503
- By:
- Publication type:
- Article
Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e398, doi. 10.1634/theoncologist.2018-0883
- By:
- Publication type:
- Article
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e405, doi. 10.1634/theoncologist.2019-0698
- By:
- Publication type:
- Article
Intratumoral Immunotherapy—Update 2019.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e423, doi. 10.1634/theoncologist.2019-0438
- By:
- Publication type:
- Article
Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e439, doi. 10.1634/theoncologist.2019-0493
- By:
- Publication type:
- Article
The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e451, doi. 10.1634/theoncologist.2019-0291
- By:
- Publication type:
- Article
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD‐L1 in Gastric Cancer Patients Treated with Either Adjuvant 5‐FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA‐S Trial
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e460, doi. 10.1634/theoncologist.2019-0471
- By:
- Publication type:
- Article
Bevacizumab in Combination with TAS‐102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e469, doi. 10.1634/theoncologist.2019-0541
- By:
- Publication type:
- Article
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e477, doi. 10.1634/theoncologist.2019-0562
- By:
- Publication type:
- Article
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e484, doi. 10.1634/theoncologist.2019-0578
- By:
- Publication type:
- Article
Computed Tomography‐Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e492, doi. 10.1634/theoncologist.2019-0590
- By:
- Publication type:
- Article
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First‐Line Palliative Chemotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e502, doi. 10.1634/theoncologist.2019-0085
- By:
- Publication type:
- Article
Lenvatinib Versus Sorafenib as First‐Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e512, doi. 10.1634/theoncologist.2019-0501
- By:
- Publication type:
- Article
PD‐L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e520, doi. 10.1634/theoncologist.2019-0557
- By:
- Publication type:
- Article
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e528, doi. 10.1634/theoncologist.2019-0751
- By:
- Publication type:
- Article
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
- By:
- Publication type:
- Article
Mutation Variants and Co‐Mutations as Genomic Modifiers of Response to Afatinib in HER2‐Mutant Lung Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e545, doi. 10.1634/theoncologist.2019-0547
- By:
- Publication type:
- Article
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e555, doi. 10.1634/theoncologist.2019-0463
- By:
- Publication type:
- Article
Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e570, doi. 10.1634/theoncologist.2019-0470
- By:
- Publication type:
- Article
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e578, doi. 10.1634/theoncologist.2019-0453
- By:
- Publication type:
- Article
Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) Chemotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e589, doi. 10.1634/theoncologist.2019-0527
- By:
- Publication type:
- Article
Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e598, doi. 10.1634/theoncologist.2019-0523
- By:
- Publication type:
- Article
The Impact of Nonsteroidal Anti‐Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti‐PD‐1 Therapy in Advanced Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e602, doi. 10.1634/theoncologist.2019-0518
- By:
- Publication type:
- Article
Fluoropyrimidine‐Associated Cardiotoxicity: A Retrospective Case‐Control Study.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e606, doi. 10.1634/theoncologist.2019-0762
- By:
- Publication type:
- Article